ATE206129T1 - Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper - Google Patents

Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper

Info

Publication number
ATE206129T1
ATE206129T1 AT90916421T AT90916421T ATE206129T1 AT E206129 T1 ATE206129 T1 AT E206129T1 AT 90916421 T AT90916421 T AT 90916421T AT 90916421 T AT90916421 T AT 90916421T AT E206129 T1 ATE206129 T1 AT E206129T1
Authority
AT
Austria
Prior art keywords
human
protein
production
directed against
antibodies directed
Prior art date
Application number
AT90916421T
Other languages
English (en)
Inventor
Charles R King
Patricia S Steeg
Lance A Liotta
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE206129T1 publication Critical patent/ATE206129T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90916421T 1989-10-18 1990-10-17 Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper ATE206129T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42280189A 1989-10-18 1989-10-18
PCT/US1990/005849 WO1991005793A1 (en) 1989-10-18 1990-10-17 Production and use of human nm23 protein and antibodies therefor

Publications (1)

Publication Number Publication Date
ATE206129T1 true ATE206129T1 (de) 2001-10-15

Family

ID=23676440

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90916421T ATE206129T1 (de) 1989-10-18 1990-10-17 Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper

Country Status (10)

Country Link
US (3) US6423836B1 (de)
EP (1) EP0495910B1 (de)
JP (2) JP2758500B2 (de)
AT (1) ATE206129T1 (de)
AU (1) AU643971B2 (de)
CA (1) CA2067797C (de)
DE (1) DE69033810T2 (de)
DK (1) DK0495910T3 (de)
ES (1) ES2164634T3 (de)
WO (1) WO1991005793A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770386A (en) * 1992-05-20 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
WO1998044088A2 (en) * 1997-04-03 1998-10-08 Joslin Diabetes Center, Inc. Modulating the rad-nm23 interaction
US20020197253A1 (en) * 2001-05-22 2002-12-26 Cheek Dennis J. Compositions and methods for promoting or inhibiting NDPK
GB0124145D0 (en) * 2001-10-08 2001-11-28 Bayer Ag Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease
TWI281473B (en) * 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
US8450279B2 (en) 2007-09-04 2013-05-28 Procell Therapeutics Inc. Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
CA2830503A1 (en) 2011-03-17 2012-09-20 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
WO2012154759A2 (en) * 2011-05-09 2012-11-15 Minerva Biotechnologies Corporation Genetically engineered growth factor variants

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35097A (en) * 1862-04-29 Improvement in machines for upsetting tires
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4808528A (en) * 1983-05-19 1989-02-28 Karl Tryggvason Antibody composition for the detection of malignant cells with metastatic cell activity
US4816400A (en) * 1983-05-19 1989-03-28 Karl Tryggvason Basement membrane collagen degrading enzyme and method of purifying same
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
EP0203970A1 (de) * 1984-11-30 1986-12-10 Whitehead Institute For Biomedical Research Übertragbare säugetiergene verbunden mit tumor-metastasen
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
US5049662A (en) 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
JPH01156999A (ja) * 1988-09-03 1989-06-20 Dainippon Pharmaceut Co Ltd ヒト癌壊死因子
EP0498849A1 (de) * 1989-10-31 1992-08-19 Institut Pasteur Verfahren zum nachweis vorwiegend proliferierender zellen
FR2653781B1 (fr) * 1989-10-31 1992-02-07 Pasteur Institut Procede de synthese de derives d'adenosine phosphate et derives obtenus.
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein

Also Published As

Publication number Publication date
EP0495910A1 (de) 1992-07-29
US6423836B1 (en) 2002-07-23
DE69033810T2 (de) 2002-03-28
JP3295358B2 (ja) 2002-06-24
US6087117A (en) 2000-07-11
JP2758500B2 (ja) 1998-05-28
US6329198B1 (en) 2001-12-11
DE69033810D1 (de) 2001-10-31
CA2067797A1 (en) 1991-04-19
CA2067797C (en) 1997-03-04
AU643971B2 (en) 1993-12-02
AU7042491A (en) 1991-05-16
EP0495910A4 (en) 1993-09-15
JPH10212299A (ja) 1998-08-11
EP0495910B1 (de) 2001-09-26
WO1991005793A1 (en) 1991-05-02
DK0495910T3 (da) 2002-01-14
JPH04506457A (ja) 1992-11-12
ES2164634T3 (es) 2002-03-01

Similar Documents

Publication Publication Date Title
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
ATE299180T1 (de) Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren
TR200001646T2 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin.
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
ATE303161T1 (de) Humanisierung von anti-carcinoembryonalen antigen anti-idiotypischen antikörper und dessen verwendung als tumorvakzin und zur markierung
DE69519796D1 (de) PTPalpha-Bestimmung in der Tumordiagnose und -Prognose
MXPA03006771A (es) Anticuerpos modificados y metodos de uso.
DE60135315D1 (de) In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide
DK130387A (da) Transglutaminase inhibitorer
DE69031656D1 (de) Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung
BG101024A (bg) Моноклонално антитяло срещу сd44v6
ATE161582T1 (de) Monoklonale antikörper der maus
ATE206129T1 (de) Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper
DE68921979D1 (de) Antikörper für die antilymphozyten-antikörpertherapie.
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
IL92956A0 (en) Gene sequences which encode acylpeptide hydrolase and methods for detecting cancer utilizing the same
EP1578760A4 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von tumoren
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
ATE134874T1 (de) Synoviale phospholipasen
DE69315341D1 (de) Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.
ES8800725A1 (es) Un procedimiento para producir un anticuerpo monoclonal
DE60135232D1 (de) Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen
ATE305041T1 (de) Kompositionen und verwendungen von cgi-69
NZ502270A (en) Derivatives of mammalian secretory peptide-9 for treating cancer and may be used in conjunction with cytokines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time